Investor

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

Analyst Coverage

SEB

Research (commissioned) initiated on 30 November 2020 (see press release here).

SEB’s corporate page on FluoGuide is here.